| Date Filed | Type | Description |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2023 |
4
| Palmer Ashleigh (Director and CEO) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Sold 50,000 shares
@ $10.1111, valued at
$505.6k
Sold 25,835 shares
@ $10.0425, valued at
$259.4k
Exercised 50,000 options to buy
@ $2.5, valued at
$125k
Exercised 25,835 options to buy
@ $2.5, valued at
$64.6k
|
|
| 01/20/2023 |
4
| Palmer Ashleigh (Director and CEO) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Sold 24,165 shares
@ $10.2654, valued at
$248.1k
Exercised 24,165 options to buy
@ $2.5, valued at
$60.4k
|
|
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2022 |
4
| Palmer Ashleigh (Director and CEO) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 360,000 options to buy
@ $4.37, valued at
$1.6M
|
|
| 12/01/2021 |
4
| Palmer Ashleigh (Director and CEO) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 3,750 shares
@ $6.664, valued at
$25k
|
|
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2020 |
4
| Palmer Ashleigh (President and CEO) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 500 shares
@ $12.69, valued at
$6.3k
|
|
| 08/17/2020 |
4
| Palmer Ashleigh (President and CEO) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 2,800 shares
@ $12.83, valued at
$35.9k
|
|
| 07/16/2020 |
4
| Palmer Ashleigh (President and CEO) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 137,750 options to buy
@ $12.62, valued at
$1.7M
|
|
| 02/14/2020 |
SC 13G/A
| Palmer Ashleigh reports a 6.1% stake in Provention Bio, Inc. |
| 12/23/2019 |
4
| Palmer Ashleigh (President and CEO) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 2,075 shares
@ $11.39, valued at
$23.6k
|
|
| 09/24/2019 |
4
| Palmer Ashleigh (President and CEO) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 3,000 shares
@ $8.38, valued at
$25.1k
|
|
| 08/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2019 |
4
| Palmer Ashleigh (President & CEO) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 400,000 options to buy
@ $12.54, valued at
$5M
|
|
| 06/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/31/2018 |
4
| Palmer Ashleigh (President and CEO) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 5,000 shares
@ $1.73, valued at
$8.7k
Bought 825 shares
@ $1.58, valued at
$1.3k
|
|
| 07/19/2018 |
4
| Palmer Ashleigh (President and CEO) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Bought 37,500 shares
@ $4, valued at
$150k
|
|
| 07/03/2018 |
3
| Palmer Ashleigh (President and CEO) has filed a Form 3 on Provention Bio, Inc. |
| 12/11/2012 |
4
| Palmer Ashleigh (CEO) has filed a Form 4 on UNIGENE LABORATORIES INC|
Txns:
| Disposed/sold 660,000 options
@ $0.25, valued at
$165k
|
|
| 10/01/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/22/2011 |
4
| Palmer Ashleigh (President & CEO) has filed a Form 4 on UNIGENE LABORATORIES INC|
Txns:
| Bought 2,500 shares
@ $0.525, valued at
$1.3k
Bought 7,500 shares
@ $0.53, valued at
$4k
|
|
| 09/21/2010 |
4
| Palmer Ashleigh (President & CEO) has filed a Form 4 on UNIGENE LABORATORIES INC|
Txns:
| Bought 8,800 shares
@ $0.7, valued at
$6.2k
|
|
| 08/12/2010 |
4
| Palmer Ashleigh (President & CEO) has filed a Form 4 on UNIGENE LABORATORIES INC|
Txns:
| Bought 20,000 shares
@ $0.6, valued at
$12k
|
|
| 06/21/2010 |
4
| Palmer Ashleigh (President & CEO) has filed a Form 4 on UNIGENE LABORATORIES INC|
Txns:
| Bought 2,500 shares
@ $0.77, valued at
$1.9k
Bought 18,700 shares
@ $0.8, valued at
$15k
|
|
| 06/17/2010 |
4
| Palmer Ashleigh (President & CEO) has filed a Form 4 on UNIGENE LABORATORIES INC|
Txns:
| Granted 166,667 options
@ $0.77, valued at
$128.3k
Granted 166,666 options
@ $0.77, valued at
$128.3k
|
|
| 06/11/2010 |
3
| Palmer Ashleigh (President & CEO) has filed a Form 3 on UNIGENE LABORATORIES INC |